Irena Sniecinski

2.6k total citations
49 papers, 1.8k citations indexed

About

Irena Sniecinski is a scholar working on Hematology, Oncology and Immunology. According to data from OpenAlex, Irena Sniecinski has authored 49 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Hematology, 20 papers in Oncology and 8 papers in Immunology. Recurrent topics in Irena Sniecinski's work include Hematopoietic Stem Cell Transplantation (21 papers), Blood groups and transfusion (9 papers) and CAR-T cell therapy research (7 papers). Irena Sniecinski is often cited by papers focused on Hematopoietic Stem Cell Transplantation (21 papers), Blood groups and transfusion (9 papers) and CAR-T cell therapy research (7 papers). Irena Sniecinski collaborates with scholars based in United States, United Kingdom and Italy. Irena Sniecinski's co-authors include MR O’Donnell, Barbara Nowicki, LR Hill, Stephen J. Forman, Auayporn Nademanee, Karl G. Blume, Anthony S. Stein, Margaret O’Donnell, David Ciavarella and Thomas H. Price and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Irena Sniecinski

49 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Irena Sniecinski United States 22 1.1k 510 375 339 281 49 1.8k
MR O’Donnell United States 16 982 0.9× 358 0.7× 150 0.4× 234 0.7× 208 0.7× 25 1.4k
GL Phillips Canada 25 1.8k 1.7× 1.1k 2.2× 575 1.5× 532 1.6× 524 1.9× 56 3.0k
Dennis Cooper United States 27 951 0.9× 1.1k 2.2× 466 1.2× 670 2.0× 256 0.9× 112 2.8k
Eeva Juvonen Finland 30 1.6k 1.5× 619 1.2× 440 1.2× 274 0.8× 1.1k 3.8× 83 2.8k
Daniel H. Ryan United States 21 616 0.6× 298 0.6× 596 1.6× 104 0.3× 189 0.7× 69 2.1k
H. Wandt Germany 21 683 0.6× 596 1.2× 134 0.4× 495 1.5× 382 1.4× 48 1.9k
FR Appelbaum United States 17 1.9k 1.7× 647 1.3× 384 1.0× 76 0.2× 571 2.0× 19 2.4k
NC Gorin France 24 1.3k 1.3× 516 1.0× 206 0.5× 181 0.5× 415 1.5× 55 1.8k
Oumédaly Reman France 20 635 0.6× 385 0.8× 111 0.3× 362 1.1× 236 0.8× 61 1.4k
N. Schwella Germany 19 588 0.6× 637 1.2× 262 0.7× 85 0.3× 128 0.5× 54 1.4k

Countries citing papers authored by Irena Sniecinski

Since Specialization
Citations

This map shows the geographic impact of Irena Sniecinski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Irena Sniecinski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Irena Sniecinski more than expected).

Fields of papers citing papers by Irena Sniecinski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Irena Sniecinski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Irena Sniecinski. The network helps show where Irena Sniecinski may publish in the future.

Co-authorship network of co-authors of Irena Sniecinski

This figure shows the co-authorship network connecting the top 25 collaborators of Irena Sniecinski. A scholar is included among the top collaborators of Irena Sniecinski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Irena Sniecinski. Irena Sniecinski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sniecinski, Irena & Jerard Seghatchian. (2017). Factual reflections and recommendations on extracorporeal photopheresis in pediatrics. Transfusion and Apheresis Science. 56(2). 118–122. 11 indexed citations
2.
Perotti, Cesare & Irena Sniecinski. (2015). A concise review on extracorporeal photochemotherapy: Where we began and where we are now and where are we going!. Transfusion and Apheresis Science. 52(3). 360–368. 19 indexed citations
3.
Ballen, Karen K., Julie A. Hicks, B. Dharan, et al.. (2002). Racial and ethnic composition of volunteer cord blood donors: comparison with volunteer unrelated marrow donors. Transfusion. 42(10). 1279–1284. 38 indexed citations
4.
Krouse, Robert S., Stephen J. Forman, David Senitzer, et al.. (2002). Immunogenicity of a p210(BCR-ABL) fusion domain candidate DNA vaccine targeted to dendritic cells by a recombinant adeno-associated virus vector in vitro.. PubMed. 62(11). 3175–83. 30 indexed citations
5.
Krishnan, Amrita, Ravi Bhatia, Marilyn L. Slovak, et al.. (2000). Predictors of therapy-related leukemia and myelodysplasia following autologous transplantation for lymphoma: an assessment of risk factors. Blood. 95(5). 1588–1593. 205 indexed citations
6.
Dzik, Sunny, et al.. (1999). Toward standardization of CD34+ cell enumeration: an international study. Transfusion. 39(8). 856–863. 19 indexed citations
7.
Nademanee, Auayporn, Arturo Molina, Henry C. Fung, et al.. (1999). High-dose chemo/radiotherapy and autologous bone marrow or stem cell transplantation for poor-risk advanced-stage Hodgkin's disease during first partial or complete remission. Biology of Blood and Marrow Transplantation. 5(5). 292–298. 17 indexed citations
8.
McLeod, Bruce C., Thomas H. Price, H. Owen, et al.. (1998). Frequency of immediate adverse effects associated with apheresis donation. Transfusion. 38(10). 938–943. 100 indexed citations
10.
Somlo, George, James H. Doroshow, Stephen J. Forman, et al.. (1994). High-dose cisplatin, etoposide, and cyclophosphamide with autologous stem cell reinfusion in patients with responsive metastatic or high-risk primary breast cancer. Cancer. 73(1). 125–134. 28 indexed citations
11.
Okarma, T B, Jane Lebkowski, Edward F. Srour, et al.. (1992). The AIS CELLector: a new technology for stem cell purification.. PubMed. 377. 487–502; discussion 503. 6 indexed citations
12.
Hwang, David, Arye Lev-Ran, Cindy F. Yen, & Irena Sniecinski. (1992). Release of different fractions of epidermal growth factor from human platelets in vitro: preferential release of 140 kDa fraction. Regulatory Peptides. 37(2). 95–100. 16 indexed citations
13.
Snyder, David S., John J. Rossi, Jean Wang, et al.. (1991). PERSISTENCE OF bcr-abl GENE EXPRESSION FOLLOWING BONE MARROW TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA IN CHRONIC PHASE. Transplantation. 51(5). 1033–1039. 24 indexed citations
14.
Sniecinski, Irena, et al.. (1989). Preparation of leukocyte‐poor platelets by Filtration. Journal of Clinical Apheresis. 5(1). 7–11. 2 indexed citations
15.
Boldt, David H., Bonnie Mills, Brett T. Gemlo, et al.. (1988). Laboratory correlates of adoptive immunotherapy with recombinant interleukin-2 and lymphokine-activated killer cells in humans.. PubMed. 48(15). 4409–16. 67 indexed citations
16.
Sniecinski, Irena, et al.. (1988). Apheresis techniques in lymphokine‐activated killer cell production. Journal of Clinical Apheresis. 4(2-3). 108–112. 1 indexed citations
17.
Pineda, Alvaro A., Irena Sniecinski, & H C Stevenson. (1988). An Artificial Lymph Gland: A New Approach to Cancer Therapy. Artificial Organs. 12(3). 243–247. 1 indexed citations
18.
Sniecinski, Irena. (1987). Safety of Apheresis Donation. Transfusion Medicine and Hemotherapy. 14(Suppl. 4). 52–56. 3 indexed citations
19.
Sniecinski, Irena, et al.. (1981). Histocompatibility-antigen distribution in patients with cervical and endometrial carcinomas. Gynecologic Oncology. 11(1). 68–74. 5 indexed citations
20.
Pavone, B. G., et al.. (1981). An auto‐anti‐Ena, inhibitable by MN sialoglycoprotein. Transfusion. 21(1). 25–31. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026